Form D · Other

AZTherapies, INC

Boston, MA · CIK 0001629864

Offering snapshot reported Sep 15, 2020 · SEC filing

Reported sold
$14.8M
Offering amount: $35M
Investors reported
59
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 28, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 15, 2020Initial$14,825,487No comparison59SEC filing
Jul 12, 2019Initial$19,040,284No comparison25SEC filing
May 31, 2019Initial$5,608,027No comparison11SEC filing
Oct 16, 2018Amendment$16,060,491$8,334,979vs Jul 3, 201835SEC filing
Jul 3, 2018Initial$7,725,512No comparison25SEC filing
Dec 18, 2017Initial$1,570,000No comparison9SEC filing
Nov 15, 2017Amendment$6,549,969$2,880,000vs Jun 30, 201743SEC filing
Jun 30, 2017Initial$3,669,969No comparison26SEC filing
Feb 6, 2017Amendment$16,050,236$2,300,000vs Dec 7, 201541SEC filing
Dec 7, 2015Initial$13,750,236No comparison37SEC filing
Jan 6, 2015Initial$6,110,000No comparison15SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-375480

Source: Form D, filed Sep 15, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Brian Bartlett Executive
George Behrakis Director
Peter Conti Director
David Elmaleh Director, Executive
Noah Gottdiener Director
Keith Greenfield Director
Jay Mohr Executive
Thierry Porte Director
John Porter Director
Karen Reeves Executive
Gillian Sandler Director
David Taft Director
Ronald Tompkins Director
Robert S. Warren Executive

Issuer details

Industry: Other (See others in industry)

Address:
200 Clarendon Street, 17 Th Floor
Boston, MA, 02116